Adcock Ingram Holdings Limited (AIP) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.175x

Based on the latest financial reports, Adcock Ingram Holdings Limited (AIP) has a cash flow conversion efficiency ratio of 0.175x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ZAC1.02 Billion ≈ $543.77K USD) by net assets (ZAC5.83 Billion ≈ $3.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Adcock Ingram Holdings Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Adcock Ingram Holdings Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Adcock Ingram Holdings Limited balance sheet liabilities for a breakdown of total debt and financial obligations.

Adcock Ingram Holdings Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adcock Ingram Holdings Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
TUNGSTEN WEST PLC LS -01
F:540
N/A
International Tower Hill Mines Ltd
TO:ITH
-0.017x
Anhui Huaertai Chemical Co Ltd
SHE:001217
0.052x
Momentum Group AB (publ)
ST:MMGR-B
0.046x
Weikeng Industrial Co Ltd
TW:3033
-0.239x
Xingye Leather Technology Co Ltd
SHE:002674
0.020x
Danske Andelskassers Bank A/S
CO:DAB
-0.112x
Galiano Gold Inc
TO:GAU
0.260x

Annual Cash Flow Conversion Efficiency for Adcock Ingram Holdings Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Adcock Ingram Holdings Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see AIP market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 ZAC5.83 Billion
≈ $3.10 Million
ZAC432.43 Million
≈ $229.82K
0.074x -57.49%
2024-06-30 ZAC5.41 Billion
≈ $2.88 Million
ZAC943.83 Million
≈ $501.60K
0.174x +146.10%
2023-06-30 ZAC5.39 Billion
≈ $2.86 Million
ZAC381.75 Million
≈ $202.88K
0.071x -43.46%
2022-06-30 ZAC5.25 Billion
≈ $2.79 Million
ZAC657.33 Million
≈ $349.34K
0.125x +25.07%
2021-06-30 ZAC4.68 Billion
≈ $2.49 Million
ZAC469.27 Million
≈ $249.39K
0.100x -13.52%
2020-06-30 ZAC4.54 Billion
≈ $2.41 Million
ZAC525.88 Million
≈ $279.48K
0.116x -1.57%
2019-06-30 ZAC4.30 Billion
≈ $2.28 Million
ZAC505.96 Million
≈ $268.89K
0.118x +20.35%
2018-06-30 ZAC3.91 Billion
≈ $2.08 Million
ZAC382.93 Million
≈ $203.51K
0.098x -24.94%
2017-06-30 ZAC3.50 Billion
≈ $1.86 Million
ZAC455.43 Million
≈ $242.04K
0.130x -18.77%
2016-06-30 ZAC3.25 Billion
≈ $1.73 Million
ZAC522.12 Million
≈ $277.48K
0.160x +16.97%
2015-06-30 ZAC3.12 Billion
≈ $1.66 Million
ZAC427.49 Million
≈ $227.19K
0.137x +282.52%
2014-06-30 ZAC2.86 Billion
≈ $1.52 Million
ZAC102.45 Million
≈ $54.45K
0.036x +579.20%
2013-06-30 ZAC3.78 Billion
≈ $2.01 Million
ZAC-28.29 Million
≈ $-15.03K
-0.007x -105.82%
2012-06-30 ZAC3.56 Billion
≈ $1.89 Million
ZAC457.66 Million
≈ $243.22K
0.129x -21.29%
2011-06-30 ZAC3.22 Billion
≈ $1.71 Million
ZAC526.38 Million
≈ $279.74K
0.163x -41.78%
2010-06-30 ZAC3.07 Billion
≈ $1.63 Million
ZAC862.10 Million
≈ $458.16K
0.281x -13.45%
2009-06-30 ZAC2.33 Billion
≈ $1.24 Million
ZAC753.69 Million
≈ $400.55K
0.324x +158.01%
2008-06-30 ZAC1.65 Billion
≈ $877.42K
ZAC207.38 Million
≈ $110.21K
0.126x -82.76%
2007-06-30 ZAC973.30 Million
≈ $517.26K
ZAC709.08 Million
≈ $376.84K
0.729x -55.21%
2006-06-30 ZAC384.76 Million
≈ $204.48K
ZAC625.83 Million
≈ $332.60K
1.627x +144.64%
2005-06-30 ZAC619.84 Million
≈ $329.41K
ZAC412.11 Million
≈ $219.02K
0.665x --

About Adcock Ingram Holdings Limited

JSE:AIP South Africa Drug Manufacturers - Specialty & Generic
Market Cap
$583.42 Million
ZAC1.10 Trillion ZAC
Market Cap Rank
#11790 Global
#88 in South Africa
Share Price
ZAC7480.00
Change (1 day)
+0.13%
52-Week Range
ZAC4800.00 - ZAC7480.00
All Time High
ZAC7480.00
About

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products… Read more